Perioperative Durvalumab Benefit
Clinical caseGastroenterology2 min
An adult with histologically documented, previously untreated, resectable stage II-IVa gastric adenocarcinoma is eligible for radical surgery. The oncology team is considering perioperative systemic treatment options.